The management of anti-tuberculosis drug-induced hepatotoxicity.

2001103 citationsJournal Article

Authors

Kemal Tahaoğlu · Ankara Spine Center

G Ataç

Tülin Sevim

Tushar Tarun

Özlem Moçin Yazıcıoğlu

Abstract

The recurrence rate of hepatotoxicity in the retreatment of tuberculosis is higher in the reintroduction of a full-dose regimen including pyrazinamide, which causes more hepatotoxicity than gradual reintroduction of a regimen without pyrazinamide.

Topics & Keywords

Drug-Induced Hepatotoxicity and Protection Liver Disease Diagnosis and Treatment Hepatitis C virus research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 5, Issue 1, pp. 65-9

Field-Weighted Citation Impact: 2.35